Financials
- Market Capitalization 21.15 M
- Employee 18
- Founded 2020
- CEO N/A
- Website www.tevogen.com
- Headquarter Delaware, United States
- FIGI BBG013395405
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.05
Rapporto prezzo/fatturato
-280.95
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4592 | ALGS Aligos Therapeutics, Inc. - Common stock | 6.17 USD | -2.99% | -0.64% | +16.42% | -36.98% | 21.37 M USD | ||
| 4595 | VYNE VYNE Therapeutics Inc. - Common Stock | 0.71 USD | +7.58% | +7.58% | +9.23% | -46.21% | 23.68 M USD | ||
| 4599 | CLRB Cellectar Biosciences, Inc. - Common Stock | 2.71 USD | +3.04% | +1.88% | +17.83% | -13.69% | 21.66 M USD | ||
| 4602 | SKYE Skye Bioscience, Inc. - Common Stock | 0.60 USD | -9.09% | -16.67% | -24.05% | -25.00% | 21.09 M USD |